Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Caldibacillus thermoamylovorans

ABSTRACT: Whole Genome Sequencing of Bacillus thermoamylovorans JQ3

PROVIDER: PRJNA810568 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18149614_1.fastq.gz	Fastqsanger.gz
	SRR18149614_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Caldibacillus thermoamylovorans

Project description:Bacillus thermoamylovorans overview

| PRJNA270783 | ENA

Caldibacillus thermoamylovorans

Project description:Draft Genome Sequences of Four Spore- Forming Food Isolates of Bacillus thermoamylovorans

| PRJNA270599 | ENA

Caldibacillus thermoamylovorans strain:R4.1

Project description:Caldibacillus thermoamylovorans strain:R4.1 Genome sequencing

| PRJNA1299081 | ENA

Caldibacillus thermoamylovorans strain:H2

Project description:Caldibacillus thermoamylovorans strain:H2 Genome sequencing

| PRJNA1368457 | ENA

Caldibacillus thermoamylovorans strain:GWC03

Project description:Caldibacillus thermoamylovorans strain:GWC03 Genome sequencing and assembly

| PRJNA977847 | ENA

Draft genome sequence of Bacillus thermoamylovorans 1A1

Project description:Draft genome sequence of Bacillus thermoamylovorans 1A1

| PRJEB6526 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Caldibacillus debilis GB1

Project description:Caldibacillus debilis GB1 Genome sequencing and assembly

| PRJNA205549 | ENA

Caldibacillus sp. NES_3

Project description:Caldibacillus sp. NES_3 Genome sequencing and assembly

| PRJNA822060 | ENA

Cell envelope metabolism in phosphate limited Bacillus subtilis cells

Project description:Investigation of the whole genome expression level changes in phosphate limited Bacillus subtilis wild-type and delta-phoPR cells Investigation of the whole genome expression level changes of wild-type and delta-phoPR Bacills subtilis cells comparing high and low phosphate medium

2011-07-13 | GSE23164 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data